Malaghan Institute of Medical Research
Research institute in Wellington, New ZealandWikipedia
9
MENTIONS
5
EPISODES
4
PODCASTS
Search complete. 9 mentions across 5 episodes found for "Malaghan Institute of Medical Research".
Oct 20, 2026
Gerry BrownleeGUEST
We have a, um, a novel third generation CAR-T product.
Gerry BrownleeGUEST
So a genetically modified, uh, product that is, uh, in currently in trials, phase two trials with the Malaghan Institute for non-Hodgkin's lymphoma across New Zealand.
Gerry BrownleeGUEST
And so far we've treat, we've treated in aggregate thirty patients in our phase one trial and, and nearly forty in our phase two trial, um, out of sixty.
Gerry BrownleeGUEST
So that's the, that's the therapy itself that we, that we have, um, that will be hopefully ready for patients in, uh, the early twenty twenty-eight.
John RobsonGUEST
No, quite the opposite.
John RobsonGUEST
Um, the assets that are available around the world, uh, we consider to be inferior.
John RobsonGUEST
The one that's been developed here with the Malaghan Institute is the world's first third-generation CAR.
John RobsonGUEST
So it is a, a CAR with a superior safety profile, um, developed, uh, over the last five-plus years.
John RobsonGUEST
Yeah, we have a, um, a novel third generation CAR-T product.
John RobsonGUEST
So a genetically modified, uh, product that is, uh, in, currently in trials, phase 2 trials with the Malaghan Institute for non-Hodgkin's lymphoma across New Zealand, and so far we've treat- we've treated in aggregate 30 patients in our phase 1 trial and, and nearly 40 in our phase 2 trial, um, out of 60.
John RobsonGUEST
So that's the, that's the therapy itself that we, that we have, um, that will be hopefully ready for patients in, uh, the early 2028.
John RobsonGUEST
But the manufacturing is the complexity, Mike.
John RobsonGUEST
No, quite the opposite.
John RobsonGUEST
Um, the assets that are available around the world, uh, we consider to be inferior.
John RobsonGUEST
The one that's been developed here with the Malaghan Institute is the world's first third generation CAR.
John RobsonGUEST
So it is a, a CAR with a superior safety profile, um, developed, uh, over the last five plus years.
Selwyn ManuHOST
A scientist is hoping to develop a vaccine that would allow older people to live longer, healthier lives.
Selwyn ManuHOST
New Zealand's Malaghan Institute and Scotland's University of Dundee are collaborating on a project to build a detailed picture of how immune cells change with age.
Selwyn ManuHOST
The institute's chief scientist, Michelle Linterman, says age-related changes in how immune cells make and manage their proteins is the reason why vaccines lose their protective power as people get older.
Michelle LintermanSOUNDBITE_SPEAKER
Better vaccines for older adults would mean fewer hospitalizations, but it would also mean a better quality of life for older adults, and that's something that we all want, you know, for our whānau, for ourselves as we all age.
speaker_0HOST
The leader of a project to build a world-first detailed picture of how immune cells change with age is hoping to develop a more effective vaccine for older people.
speaker_0HOST
The project is a collaboration between New Zealand's Malaghan Institute and Scotland's University of Dundee.
speaker_0HOST
The institute's chief scientist, Michelle Lentiman, says vaccines work less well as people get older, leaving them more vulnerable.
Michelle LentimanSOUNDBITE_SPEAKER
It's kind of like a housekeeper keeping your house in order that, you know, if something gets broken, it gets disposed of.
Lisa OwenHOST
They're a campaign group looking to improve access to modern medicines.
Lisa OwenHOST
Uh, and National has also promised to unlock CAR T-cell therapy for cancer patients, saying it would invest 25 million in the company developing the technology alongside the Malaghan Institute.
Lisa OwenHOST
BioAura says it welcomes the funding commitment and the promise of easier access to clinical trials.
Lisa OwenHOST
And National says it would set a target of 5% of Kiwis with cancer getting access to a clinical trial as part of their treatment within the next 10 years, and that would bring New Zealand in line with Australia.